Full metadata record
DC FieldValueLanguage
dc.contributor.authorSchick, Céline-
dc.contributor.authorSpineli, Loukia M-
dc.contributor.authorRaio, Luigi-
dc.contributor.authorGross, Mechthild M.-
dc.date.accessioned2021-01-28T09:38:58Z-
dc.date.available2021-01-28T09:38:58Z-
dc.date.issued2020-
dc.identifier.issn0266-6138de_CH
dc.identifier.issn1532-3099de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/21426-
dc.description.abstractObjectives The primary objective of this study was to examine the association between the first assessed cervical dilatation in a labourward and the use of oxytocin augmentation during labour. Further analysis was performed by examining the actual stage of labour at the point oxytocin was first administered to those women. Design Retrospective cohort study with the data collected from the medical records of the hospital. Setting University Hospital Bern, Switzerland Participants 1933 term nulliparous and multiparous women with a singleton pregnancy giving birth during the period June 2013 and May 2017, representing Robson groups 1 and 3. Measurements and findings Descriptive statistics and multivariable logistic regression models were performed. It was found that for the entire process of labour, nulliparous and multiparous women (n = 1933) with a first cervical dilatation of 5 or more cm were less likely to be augmented with oxytocin (OR 0.64, 95% CI 0.46; 0.88 and OR 0.56, 95% CI 0.38; 0.82, respectively) compared to women with a first cervical dilatation of less than 5 cm. Out of these augmented women (n = 746) having a first cervical dilatation of 5 or more cm, they had a lower likelihood of being augmented during the first stage of labour compared to women with a first cervical dilatation of less than 5 cm (OR 0.45, 95% CI 0.29; 0.7 for nulliparae and OR 0.32, 95% CI 0.16; 0.6 for multiparae). Additionally, it was observed that other factors contributed to the application of oxytocin. One such example was that epidural analgesia was associated with a high risk of oxytocin augmentation in nulliparae (OR 13.88, 95% CI 9.29; 20.74) and multiparae (OR 15.52, 95% CI 9.94; 24.22). The application of oxytocin was also found to affect the caesarean section rate in nulliparous and multiparous women as it was 20% and 13% respectively for those with oxytocin versus 13% and 4% respectively for those without oxytocin. Key conclusions Early admission to the labourward is associated with an increased use of oxytocin to augment labour, particularly, during the first stage of labour. Epidural analgesia is a main predictor for oxytocin augmentation in nulliparous and multiparous women. Implications for practice Pregnant women warrant more appropriate support during early labour, avoiding early maternal exhaustion and excessive obstetrical interventions.de_CH
dc.language.isoende_CH
dc.publisherElsevierde_CH
dc.relation.ispartofMidwiferyde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subjectAdmissionde_CH
dc.subjectCervical dilatationde_CH
dc.subjectEpidural analgesiade_CH
dc.subjectLabour dystociade_CH
dc.subjectMidwifery carede_CH
dc.subjectOxytocin augmentationde_CH
dc.subject.ddc618.4: Geburtde_CH
dc.titleFirst assessed cervical dilatation: is it associated with oxytocin augmentation during labour? : a retrospective cohort study in a university hospital in Switzerlandde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementGesundheitde_CH
zhaw.organisationalunitInstitut für Hebammenwissenschaft und reproduktive Gesundheit (IHG)de_CH
dc.identifier.doi10.1016/j.midw.2020.102683de_CH
dc.identifier.pmid32200140de_CH
zhaw.funding.euNode_CH
zhaw.issue102683de_CH
zhaw.originated.zhawYesde_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume85de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen Gesundheit

Files in This Item:
There are no files associated with this item.
Show simple item record
Schick, C., Spineli, L. M., Raio, L., & Gross, M. M. (2020). First assessed cervical dilatation: is it associated with oxytocin augmentation during labour? : a retrospective cohort study in a university hospital in Switzerland. Midwifery, 85(102683). https://doi.org/10.1016/j.midw.2020.102683
Schick, C. et al. (2020) ‘First assessed cervical dilatation: is it associated with oxytocin augmentation during labour? : a retrospective cohort study in a university hospital in Switzerland’, Midwifery, 85(102683). Available at: https://doi.org/10.1016/j.midw.2020.102683.
C. Schick, L. M. Spineli, L. Raio, and M. M. Gross, “First assessed cervical dilatation: is it associated with oxytocin augmentation during labour? : a retrospective cohort study in a university hospital in Switzerland,” Midwifery, vol. 85, no. 102683, 2020, doi: 10.1016/j.midw.2020.102683.
SCHICK, Céline, Loukia M SPINELI, Luigi RAIO und Mechthild M. GROSS, 2020. First assessed cervical dilatation: is it associated with oxytocin augmentation during labour? : a retrospective cohort study in a university hospital in Switzerland. Midwifery. 2020. Bd. 85, Nr. 102683. DOI 10.1016/j.midw.2020.102683
Schick, Céline, Loukia M Spineli, Luigi Raio, and Mechthild M. Gross. 2020. “First Assessed Cervical Dilatation: Is It Associated with Oxytocin Augmentation during Labour? : A Retrospective Cohort Study in a University Hospital in Switzerland.” Midwifery 85 (102683). https://doi.org/10.1016/j.midw.2020.102683.
Schick, Céline, et al. “First Assessed Cervical Dilatation: Is It Associated with Oxytocin Augmentation during Labour? : A Retrospective Cohort Study in a University Hospital in Switzerland.” Midwifery, vol. 85, no. 102683, 2020, https://doi.org/10.1016/j.midw.2020.102683.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.